cytosine and Carcinoma, Transitional Cell
cytosine has been researched along with Carcinoma, Transitional Cell in 9 studies
Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"To investigate efficacy and safety of bropirimine, a new orally active interferon inducer, in patients with superficial bladder cancer." | 7.70 | Bropirimine, an orally active anticancer agent for superficial bladder cancer. ( Akaza, H; Kotake, T; Machida, T, 1998) |
"To investigate efficacy and safety of bropirimine, a new orally active interferon inducer, in patients with superficial bladder cancer." | 3.70 | Bropirimine, an orally active anticancer agent for superficial bladder cancer. ( Akaza, H; Kotake, T; Machida, T, 1998) |
Research
Studies (9)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 5 (55.56) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Li, J | 1 |
Xu, Y | 1 |
Zhang, Z | 2 |
Zhang, M | 1 |
Zhang, F | 1 |
Li, Q | 1 |
Schenkman, E | 1 |
Lamm, DL | 2 |
Perabo, FG | 1 |
Müller, SC | 1 |
Akaza, H | 2 |
Kotake, T | 1 |
Machida, T | 1 |
Sargent, ER | 1 |
Williams, RD | 2 |
Sarosdy, MF | 1 |
Moon, TD | 1 |
Flanigan, RC | 1 |
Crawford, ED | 1 |
Wilks, NE | 1 |
Earhart, RH | 1 |
Merritt, JA | 1 |
Borden, EC | 1 |
Sidky, YA | 1 |
Ertürk, E | 1 |
Wierenga, W | 1 |
Bryan, GT | 1 |
Del Senno, L | 1 |
Maestri, I | 1 |
Piva, R | 1 |
Hanau, S | 1 |
Reggiani, A | 1 |
Romano, A | 1 |
Russo, G | 1 |
Reviews
4 reviews available for cytosine and Carcinoma, Transitional Cell
Article | Year |
---|---|
Superficial bladder cancer therapy.
Topics: Administration, Intravesical; Antineoplastic Agents; BCG Vaccine; Carcinoma, Transitional Cell; Cyto | 2004 |
Current and new strategies in immunotherapy for superficial bladder cancer.
Topics: Adjuvants, Immunologic; Administration, Intravesical; Administration, Oral; Antineoplastic Agents; A | 2004 |
New strategy of bio-chemoprevention on recurrence of superficial bladder cancer based on a hypothesis of the mechanism of recurrence.
Topics: Administration, Intravesical; Animals; BCG Vaccine; Butylhydroxybutylnitrosamine; Carcinoma, Transit | 1997 |
Immunotherapeutic alternatives in superficial bladder cancer. Interferon, interleukin-2, and keyhole-limpet hemocyanin.
Topics: Adjuvants, Immunologic; Carcinoma, Transitional Cell; Cytosine; Hemocyanins; Humans; Interferon Indu | 1992 |
Other Studies
5 other studies available for cytosine and Carcinoma, Transitional Cell
Article | Year |
---|---|
[Expression and clinical significance of 5hmC in bladder urothelial carcinoma].
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Transitional Cell; C | 2016 |
Bropirimine, an orally active anticancer agent for superficial bladder cancer.
Topics: Administration, Oral; Aged; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Transitional Cell; | 1998 |
Phase 1 trial of oral bropirimine in superficial bladder cancer.
Topics: Administration, Oral; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Papillary; Carcinoma, Tra | 1992 |
Protection from carcinogen-induced murine bladder carcinoma by interferons and an oral interferon-inducing pyrimidinone, bropirimine.
Topics: Animals; Antineoplastic Agents; Carcinoma, Transitional Cell; Cytosine; Drug Evaluation, Preclinical | 1990 |
Differential hypomethylation of the c-myc protooncogene in bladder cancers at different stages and grades.
Topics: 5-Methylcytosine; Autoradiography; Blotting, Southern; Carcinoma, Transitional Cell; Cytosine; DNA, | 1989 |